NCT05875038 Superiority of Intelligent Video Surveillance + Telealarm Over Telealarm Alone in Elderly People at Risk of Falling
| NCT ID | NCT05875038 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire, Amiens |
| Condition | Intelligent Video Surveillance |
| Study Type | INTERVENTIONAL |
| Enrollment | 395 participants |
| Start Date | 2023-05-16 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 395 participants in total. It began in 2023-05-16 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Maintaining the elderly at home and preventing them from falling are major public health issues. The vast majority of elderly people wish to remain at home. The fear of a fall with prolonged standing is a frequent reason for institutionalization. There are few procedures that have been shown to be effective in preventing falls and their complications. Prolonged standing on the floor is a major complication that can lead to multiple events, including death. Tele-alarms are widely used in France and in Europe, but their effectiveness in the event of a fall is poor and their use is restrictive (they require physical and mental capacities to activate). However, elderly people at risk of falling are often frail or dependent, suffering from cognitive disorders and sometimes polymorbid, which explains the large number of failures of tele-alarms. There are other alert systems, notably intelligent video surveillance systems such as the VA2CS. This is a video system placed in the home that analyzes the position of subjects in real time using algorithms based on artificial intelligence. The system works continuously without video capture and sends an alert with a photo if a person is lying down after a fall. The alert is confirmed after an operator has checked the photo capture on a dedicated platform. To date, it has a sensitivity and specificity of over 90% (manufacturer's data not published). Its performance is equivalent to other intelligent video surveillance systems published in the literature. This system is autonomous and does not rely on the abilities of the person at risk of falling. Intelligent video surveillance is an innovative technology which has not yet been evaluated in a geriatric care program, nor compared to a reference or analyzed from a quality of life or medico-economic perspective. The hypothesis of this study is that intelligent video surveillance allows an exhaustive and early detection of the fall with a faster alert enabling to avoid prolonged standing on the ground and its consequences compared to the tele-alarm alone.
Eligibility Criteria
Inclusion Criteria: * Person aged 75 years or more * hospitalized in an acute geriatric service or in a geriatric or multipurpose rehabilitation care service * If living alone: receiving at least one visit per day from a relative or professional * Recent history of fall and monopodal support \< 5 seconds * Able to give informed consent. * Return home considered complex by the patient or their relatives due to the risk of falling at home. Exclusion Criteria: * Under legal protection * Not affiliated to a social security system * Confined to bed or chair
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05875038 clinical trial?
This trial is open to participants of all sexes, aged 75 Years or older, studying Intelligent Video Surveillance. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05875038 currently recruiting?
Yes, NCT05875038 is actively recruiting participants. Contact the research team at Deschasse.Guillaume@chu-amiens.fr for enrollment information.
Where is the NCT05875038 trial being conducted?
This trial is being conducted at Amiens, France.
Who is sponsoring the NCT05875038 clinical trial?
NCT05875038 is sponsored by Centre Hospitalier Universitaire, Amiens. The trial plans to enroll 395 participants.